Abstracts should be related to the care of people with diabetes and kidney disease, are welcomed from all members of the multidisciplinary team, including students and should not exceed 250 words.
Presented at EASD 60th Annual Meeting, Madrid, September 2024
Presented at EASD 60th Annual Meeting, Madrid, September 2024
Presented at EASD 60th Annual Meeting, Madrid, September 2024
For our fourth ABCD Inspire Podcast episode, our host Dr Petra Hanson is joined by Professor Mark Evans. Mark is a Consultant Physician working in diabetes and general medicine in Cambridge University Hospitals (Addenbrookes) and a Clinical Scientist based in the University of Cambridge’s Wellcome-MRC Institute of Metabolic Science.
The ABCD audit programme was prominent at the recent EASD in Madrid with three presentations.
In a short oral presentation, Dr Emma Wilmot presented data showing that in the ABCD NHS England pilot audit of hybrid closed loop therapy (HCL) which was launched in 2021, irrespective of gender, ethnicity, age or socioeconomic status HCL is associated with similar reduction in HbA1c at 6-months.
Diabetes-related ketoacidosis (DKA) is a serious complication that requires standardised, high-quality care. Despite updates to the Joint British Diabetes Societies-Inpatient (JBDS-IP) guidelines in 2010, 2013, 2021, and 2023, research has shown significant variation in DKA care between patients. Traditional audits have fallen short in addressing this variation, which demands immediate attention.
This year marks a significant milestone as the South Asian Health Foundation (SAHF) celebrate their 25th anniversary, the theme for this landmark event is ‘Health Inequalities: Full Stop’.
A new study which found that diabetes risk increases after glucocorticoids has made headlines, including a feature on the BBC news site.
